Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 4 Interventional Results available

Effects of Dronedarone on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement

ClinicalTrials.gov ID: NCT01198873

Public ClinicalTrials.gov record NCT01198873. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 10:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Placebo-Controlled, Double-Blind, Randomized, Multi-center Study to Assess the Effects of Dronedarone 400 mg BID on Cardiac Geometry and Function in Patients With Atrial Fibrillation and Left Atrial Enlargement

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: \- Evaluate the effect of dronedarone versus placebo (standard therapy) in slowing the progression of adverse left atrial remodeling in patients with atrial fibrillation (AF) following 12 months of treatment. Secondary Objectives: * Evaluate the effects of dronedarone versus placebo on left atrial function; * Evaluate the effects of dronedarone versus placebo on left atrial dimension; * Evaluate the effects of dronedarone versus placebo on left ventricular function (LVEF, E, E', A, E/E') * Evaluate the safety and tolerability of dronedarone.

Study identification

NCT ID
NCT01198873
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 4
Lead sponsor
Sanofi
Industry
Enrollment
76 participants

Conditions and interventions

Eligibility (public fields only)

Age range
21 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2010 (Type not available)
Primary completion
Jan 2012 (Actual)
Completion
Jan 2012 (Actual)
Last update posted
Feb 12, 2013

2010 – 2012

United States locations

U.S. sites
56
U.S. states
28
U.S. cities
54
Facility City State ZIP Site status
Investigational Site Number 840072 Phoenix Arizona 85006 —
Investigational Site Number 840015 Little Rock Arkansas 72204 —
Investigational Site Number 840086 Beverly Hills California 90211 —
Investigational Site Number 840018 Loma Linda California 92354 —
Investigational Site Number 840029 Merced California 95348 —
Investigational Site Number 840044 Redwood City California 94062 —
Investigational Site Number 840042 Santa Ana California 92704 —
Investigational Site Number 840060 Vista California 92083 —
Investigational Site Number 840057 Stamford Connecticut 06905 —
Investigational Site Number 840002 Newark Delaware 19713 —
Investigational Site Number 840063 Wilmington Delaware 19808 —
Investigational Site Number 840070 Bradenton Florida 34205 —
Investigational Site Number 840010 Jacksonville Florida 32216 —
Investigational Site Number 840071 Jupiter Florida 33458 —
Investigational Site Number 840061 Lakeland Florida 33805 —
Investigational Site Number 840096 Lauderdale Lakes Florida 33313 —
Investigational Site Number 840031 Ocala Florida 34471 —
Investigational Site Number 840074 Orlando Florida 32803 —
Investigational Site Number 840016 Ormond Beach Florida 32174 —
Investigational Site Number 840051 St. Petersburg Florida 33709 —
Investigational Site Number 840081 Roswell Georgia 30076 —
Investigational Site Number 840103 Jerseyville Illinois 62052 —
Investigational Site Number 840106 Peoria Illinois 61606 —
Investigational Site Number 840066 Elkhart Indiana 46514 —
Investigational Site Number 840099 Lexington Kentucky 40504 —
Investigational Site Number 840039 Owensboro Kentucky 42303 —
Investigational Site Number 840092 Baton Rouge Louisiana 70808 —
Investigational Site Number 840040 Auburn Maine 04210 —
Investigational Site Number 840077 Ayer Massachusetts 01432 —
Investigational Site Number 840050 Alpena Michigan 49707 —
Investigational Site Number 840041 Saginaw Michigan 48670 —
Investigational Site Number 840058 Minneapolis Minnesota 55422 —
Investigational Site Number 840101 Picayune Mississippi 39466 —
Investigational Site Number 840078 St Louis Missouri 63122 —
Investigational Site Number 840038 St Louis Missouri 63128 —
Investigational Site Number 840102 St Louis Missouri 63128 —
Investigational Site Number 840012 Kalispell Montana 59901 —
Investigational Site Number 840090 Lincoln Nebraska 68506 —
Investigational Site Number 840045 Buffalo New York 14215 —
Investigational Site Number 840055 Manhasset New York 11030 —
Investigational Site Number 840003 The Bronx New York 10468 —
Investigational Site Number 840004 Troy New York 12180 —
Investigational Site Number 840009 Maumee Ohio 43537 —
Investigational Site Number 840028 Camp Hill Pennsylvania 17011 —
Investigational Site Number 840067 Wyomissing Pennsylvania 19610 —
Investigational Site Number 840027 Wakefield Rhode Island 02879 —
Investigational Site Number 840046 Knoxville Tennessee 37917 —
Investigational Site Number 840014 Longview Texas 75605 —
Investigational Site Number 840068 Danville Virginia 24541 —
Investigational Site Number 840069 Manassas Virginia 20109 —
Investigational Site Number 840087 Richmond Virginia 23249 —
Investigational Site Number 840085 Winchester Virginia 22601 —
Investigational Site Number 840013 Burien Washington 98166 —
Investigational Site Number 840091 Spokane Washington 99204 —
Investigational Site Number 840080 Madison Wisconsin 53713 —
Investigational Site Number 840023 Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01198873, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 12, 2013 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01198873 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →